Author + information
- Received December 4, 2018
- Revision received January 22, 2019
- Accepted January 24, 2019
- Published online February 25, 2019.
- Melissa A. Daubert, MD∗ ( and )
- Pamela S. Douglas, MD
- ↵∗Address for correspondence:
Dr. Melissa A. Daubert, MD, Duke University and Duke Clinical Research Institute, 200 Morris Street, Durham, North Carolina 27701.
The incidence of heart failure (HF) is increasing, particularly among women, and constitutes a rapidly growing public health problem. The primary prevention of HF in women should involve targeted, sex-specific strategies to increase awareness, promote a heart healthy lifestyle, and improve treatments that optimally control the risk factors for HF with reduced ejection fraction and HF with preserved ejection fraction. Epidemiological and pathophysiological differences in both HF subtypes strongly suggest that sex-specific preventive strategies and risk factor reduction may be particularly beneficial. However, significant gaps in sex-specific knowledge exist and are impeding preventive efforts. To overcome these limitations, women need to be adequately represented in HF research, sex differences must be prospectively investigated, and effective sex-specific interventions should be incorporated into clinical practice guidelines. This review summarizes the existing evidence that supports the primary prevention of HF in women and identifies potential strategies that are most likely to be effective in reducing the burden of HF among women.
Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received December 4, 2018.
- Revision received January 22, 2019.
- Accepted January 24, 2019.
- 2019 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.